Clinical Laboratory Services Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Clinical Laboratory Services Market
The global clinical laboratory services market size was valued at USD 258.71 billion in 2023 and is projected to grow from USD 274.21 billion in 2024 to USD 468.15 billion by 2032, exhibiting a CAGR of 6.9% during the forecast period of 2023-2032.
The pandemic significantly impacted the clinical laboratory offerings market, with multiplied calls for COVID-19 checking out, causing strain on resources and delays in different diagnostics—labs adapted by imposing far-flung testing and safety measures. Focus on infectious disorder diagnostics overshadowed routine screenings and elective approaches, affecting revenue and clinical laboratory services market growth.
The scientific laboratory offerings marketplace is experiencing growth pushed via numerous elements. Increasing disorder burdens, fueled by persistent and infectious situations, are boosting demand for diagnostic testing. Advancements in the era are improving the performance and accuracy of checks, broadening the scope of laboratory offerings.
The clinical laboratory enterprise is the present process of a robot revolution!Labs are increasingly adopting automation technologies to streamline workflows, limit mistakes, and take a look at effects faster.Imagine automated systems managing repetitive obligations like pattern training and analysis. This no longer frees up lab technicians for more excellent complex work but notably reduces the chances of human error, impeding the rise of clinical laboratory services market share globally.The actual win here is faster turnaround times for looking at results.With faster admission to vital data, doctors can make extra informed selections, and patients can receive the remedy they want sooner due to better usual healthcare reviews.
Comprehensive Analysis of Clinical Laboratory Services Market
The scientific laboratory offerings market segmentation shows distinct development in test type, age, and price assets. Clinical chemistry dominates due to the superiority of diabetes and available at-domestic testing services. Hematology follows, pushed with the aid of blood-related problems. Genetic trying sees growth, mainly with the status quo of advanced laboratories. Microbiology & cytology are expected to develop due to growing infectious disorder cases. In age analysis, the grownup section leads, fueled by the aid of an aging population with continual problems. The public segment prevails regarding fee resources and is supported using government healthcare expenditure and favorable repayment rules. Private and out-of-pocket segments are growing due to improved disposable earnings, cognizance, and strategic tasks through key marketplace gamers.
The North American region led the medical devices market by benefitting a size of USD 109.30 billion in 2023 due to the improved healthcare spending and growing need for medical laboratory checks for routine health screenings and chronic conditions.
In the clinical laboratory services market, the growth trajectory and industry standards are significantly influenced by key players such as Laboratory Corporation of America (U.S.), Quest Diagnostics Incorporated (U.S.), Illumina, Inc. (U.S.), Eurofins Scientific (Luxembourg), DDRC SRL Diagnostics (SRL Diagnostics) (India), UNILABS (A.P. Moller Holding A/S) (Switzerland), NeoGenomics Laboratories, Inc. (U.S.), ARUP Laboratories (U.S.), and Sonic Healthcare Limited (Australia). These companies contribute to a competitive landscape, driving innovation and market advancement.
In August 2023, Redcliffe Labs collaborated with Abbott India to introduce Clinical Decision Support (CDS), branded as AlinIQ. This platform leverages Big Data Engines and Artificial Intelligence (AI) technology.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 6.9% from 2024-2032
Unit Value (USD Billion)
Segmentation ByTest Type
Clinical Chemistry
Hematology
Genetic Testing
Microbiology & Cytology
Others
By Age
Pediatric
Adult
By Source of Payment
Public
Private
Out of Pocket
By Service Provider
Hospital-based Laboratories
Stand-alone Laboratories
Clinic-based Laboratories
Others
By Region
North America (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country)
U.S.
Canada
Europe (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
China
India
Japan
Australia
Southeast Asia
Rest of the Asia Pacific
Latin America (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.